Reported Earlier, Quantum BioPharma Approves Debt Settlement Of C$123,487.43 Via Class B Shares At Deemed Price Of C$4.26 Or Lower

Loading news article.

Reported Earlier, Quantum BioPharma Approves Debt Settlement Of C$123,487.43 Via Class B Shares At Deemed Price Of C$4.26 Or Lower | WAPE

Article summary